Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease
Key facts
- Who runs it
- Tor Biering-Sørensen
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 308,978 people enrolled
- Started
- 1 Oct 2024
- Ended
- 31 May 2025
- Type of study
- Interventional, 7 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Behavioral Economic Principles
- Record updated
- 12 September 2025
Who can take part
- Age
- 18 years to 64 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Age 18-64 years
- Must be registered in the Danish nationwide registries as meeting at least one of the following eligibility criteria for free-of-charge influenza vaccination in the Danish public health system:; Chronic lung disease; Chronic cardiovascular disease other than hypertension; Type 1 or type 2 diabetes mellitus; Congenital or acquired immunodeficiency; Impaired breathing due to muscular weakness; Chronic renal or hepatic insufficiency; Other chronic conditions with an increased risk of severe influenza as determined by the treating physician
- Access to the official, mandatory Danish electronic mailbox system
Who cannot take part
- None
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. Conducted during the 2023/2024 influenza season, the first NUDGE-FLU-CHRONIC trial demonstrated the effectiveness of behavioral nudging letters in increasing influenza vaccination rates among adults aged 18-64 years with chronic diseases in Denmark. This present study will once again investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among adults aged 18-64 years with chronic diseases including whether the effectiveness of the previously successful strategies can be confirmed during a subsequent influenza season.
The 7 groups in the trial
- Usual CareNo study treatment, for comparison
No letter
- Standard LetterTreatment being tested
This group will receive a standard letter on the benefits of influenza vaccination without behavioral economic enhancement
Treatment: Behavioral Economic Principles
- Repeated LetterTreatment being tested
The standard letter sent out two times instead of once
Treatment: Behavioral Economic Principles
- Cardiovascular Gain-Framing LetterTreatment being tested
Text added to the standard letter highlighting potential cardiovascular benefits of influenza vaccination
Treatment: Behavioral Economic Principles
- Repeated Cardiovascular Gain-Framing LetterTreatment being tested
The cardiovascular gain-framing letter sent out two times instead of once
Treatment: Behavioral Economic Principles
- Respiratory Gain-Framing LetterTreatment being tested
Text added to the standard letter highlighting potential respiratory disease-related benefits of influenza vaccination
Treatment: Behavioral Economic Principles
- Implementation Intention Prompt LetterTreatment being tested
Implementation intention prompt added to the standard letter
Treatment: Behavioral Economic Principles
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 12 September 2025